Literature DB >> 31526216

Antidepressant-like effect induced by P2X7 receptor blockade in FSL rats is associated with BDNF signalling activation.

Deidiane E Ribeiro1,2,3,4, Heidi K Müller3, Betina Elfving3, Amanda Eskelund3, Samia Rl Joca2,3,5, Gregers Wegener3,6.   

Abstract

BACKGROUND: P2X7 receptors (P2X7R) are ligand-gated ion channels activated by adenosine 5'-triphosphate (ATP), which are involved in processes that are dysfunctional in stress response and depression, such as neurotransmitter release, and neuroimmune response. Genetic and pharmacological inhibition of the P2X7R induce antidepressant-like effects in animals exposed to stress. However, the effect of P2X7R antagonism in an animal model of depression based on selective breeding has not previously been studied, and the mechanism underling the antidepressant-like effect induced by the P2X7R blockade remains unknown. AIMS: The present study aimed to: (1) determine whether P2X7R blockade induces antidepressant-like effects in the Flinders Sensitive Line (FSL) rats and, (2) investigate whether brain-derived neurotrophic factor (BDNF) signalling in the frontal cortex and hippocampus is involved in this effect.
METHODS: FSL and the control Flinders Resistant Line (FRL) rats were treated with vehicle or the P2X7R antagonist A-804598 (3, 10 or 30 mg/Kg/day) for 1 or 7 days before being exposed to the forced swim test (FST). After the behavioural test, animals were decapitated, their brains were removed and the frontal cortex, ventral and dorsal hippocampus were dissected for BDNF signalling analysis.
RESULTS: We found that repeated treatment with A-804598 (30 mg/Kg) reduced the immobility time in the FST and activated the BDNF signalling in the ventral hippocampus of FSL rats.
CONCLUSIONS: P2X7R blockade induces an antidepressant-like effect associated with increased levels of BDNF-AKT-p70 S6 kinase in the ventral hippocampus, which may be mediated by tropomyosin-related kinase B (TRKB) receptor activation supporting the notion of P2X7R antagonism as a potential new antidepressant strategy.

Entities:  

Keywords:  P2X7 receptor; antidepressant; depression; hippocampus; rats

Year:  2019        PMID: 31526216     DOI: 10.1177/0269881119872173

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  9 in total

Review 1.  Neuroprotection of exercise: P2X4R and P2X7R regulate BDNF actions.

Authors:  Bing-Xin Sun; Ai-Shi Peng; Pei-Jie Liu; Min-Jia Wang; Hai-Li Ding; Yu-Shi Hu; Liang Kang
Journal:  Purinergic Signal       Date:  2022-07-11       Impact factor: 3.950

Review 2.  Scrutinizing the Therapeutic Promise of Purinergic Receptors Targeting Depression.

Authors:  Priyanshi Sikka; Tapan Behl; Parteek Chandel; Aayush Sehgal; Sukhbir Singh; Hafiz A Makeen; Mohammed Albratty; Hassan A Alhazmi; Abdulkarim M Meraya
Journal:  Neurotox Res       Date:  2022-08-05       Impact factor: 3.978

Review 3.  Purinergic signaling: a potential therapeutic target for depression and chronic pain.

Authors:  Yuting Zou; Runan Yang; Lin Li; Xiumei Xu; Shangdong Liang
Journal:  Purinergic Signal       Date:  2021-08-02       Impact factor: 3.765

4.  Association of P2X7 receptor genetic polymorphisms and expression with rheumatoid arthritis susceptibility in a sample of the Iranian population: a case-control study.

Authors:  Gholamreza Bahari; Farhad Tabasi; Mohammad Hashemi; Zahra Zakeri; Mohsen Taheri
Journal:  Clin Rheumatol       Date:  2021-02-12       Impact factor: 2.980

Review 5.  Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor.

Authors:  Beatriz Gil; Jonathon Smith; Yong Tang; Peter Illes; Tobias Engel
Journal:  Int J Mol Sci       Date:  2022-02-21       Impact factor: 5.923

6.  Reduced P2X receptor levels are associated with antidepressant effect in the learned helplessness model.

Authors:  Deidiane Elisa Ribeiro; Plinio C Casarotto; Laura Staquini; Maria Augusta Pinto E Silva; Caroline Biojone; Gregers Wegener; Samia Joca
Journal:  PeerJ       Date:  2019-10-21       Impact factor: 2.984

Review 7.  Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology.

Authors:  Deidiane Elisa Ribeiro; Ágatha Oliveira-Giacomelli; Talita Glaser; Vanessa F Arnaud-Sampaio; Roberta Andrejew; Luiz Dieckmann; Juliana Baranova; Claudiana Lameu; Mariusz Z Ratajczak; Henning Ulrich
Journal:  Mol Psychiatry       Date:  2020-12-16       Impact factor: 13.437

8.  Strain-, Sex-, and Time-Dependent Antidepressant-like Effects of Cannabidiol.

Authors:  Gabriela P Silote; Michelle C Gatto; Amanda Eskelund; Francisco S Guimarães; Gregers Wegener; Sâmia R L Joca
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-06

Review 9.  P2X7R antagonists in chronic stress-based depression models: a review.

Authors:  Iven-Alex von Muecke-Heim; Clemens Ries; Lidia Urbina; Jan M Deussing
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-07-19       Impact factor: 5.270

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.